The patient app · Luxembourg
Your pharmacy, right to your door.
Order from the pharmacy of your choice, ask a pharmacist your questions, and receive a sealed parcel delivered by a courier mandated by your pharmacy, under its responsibility. Dispensing a medicine remains a pharmaceutical act, at every step.
DESIGNED IN LUXEMBOURG
What never changes
Four guarantees, before anything else.
The patient app
Your pharmacy, in your pocket.
Turn, explore: every screen comes from the app itself, on demonstration data, in English for now. The app exists in French, German and English.
The catalogue, kept by the pharmacy
Swipe to explore
The principle
One app, every pharmacy.
Medelu sells nothing: your pharmacy serves you. Search the declared catalogues of the participating pharmacies, compare availability, and choose freely. The more pharmacies take part, the further the search can see.
THE APP CARRIES THE REQUEST, NEVER THE MEDICINE · PREPARED AND HANDED OVER BY THE CHOSEN PHARMACY · CATALOGUES DECLARED BY THE PARTICIPATING PHARMACIES
A medicine you cannot find nearby? The search runs through the declared catalogues of the participating pharmacies.
No paid placement, no default pharmacy: the pages are presented by proximity. You choose your pharmacy, and it stays yours.
The messaging connects you to your pharmacist, not to a call centre. Advice remains a professional act, not a chatbot.
The journey Available
One order, end to end, under pharmaceutical control.
The patient chooses their pharmacy.
Freely, with no paid placement and no steering. Real opening hours, the owner's details, direct messaging: the relationship starts the way it does at the counter.
A catalogue kept by the pharmacy, not by the platform.
Name, price incl. VAT, patient leaflet downloadable before purchase. Quantities are capped per product, and the pharmacist can refuse any order they judge inappropriate.
The price of the medicine goes directly to the pharmacy.
Payment on a PCI DSS certified page: the price of the medicine is the pharmacy's own, not a cent more, and goes to it in full.
A sealed parcel, delivered to your door.
Validation by a pharmacist, preparation at the pharmacy, tracked delivery, time-stamped proof of hand-over. Every step leaves a trace. Monday to Friday, during your pharmacy's opening hours: order one to two hours before closing and the parcel leaves the same day.
What changes everything
Six guarantees, built into the app itself.
Nothing leaves without their approval. They can refuse or cancel at any moment, and the app says so plainly.
A question about a treatment, an interaction, a dosage: you write to your pharmacist, and they answer.
Received, validated, prepared, out for delivery: you see the exact state of your order at every moment.
PCI DSS certified payment page. The price of the medicine goes directly to the pharmacy, commission-free.
Name, address, order number: nothing else appears on the parcel. Its contents remain your business.
Delivery is entrusted to a courier mandated and controlled by the pharmacy, under contract with it. The sealed parcel is left at your door, or at the sheltered spot you indicated in the app, with a time-stamped photo.
Who it matters to most
When getting there is not a detail.
Long-term treatments mean regular trips to the pharmacy. Home delivery turns them into an option, not an obligation.
29.2% of over-65s take ≥ 5 medicines/dayPeople who are dependent, convalescing or isolated: the medicine comes to them, with the same pharmaceutical control.
A sick child at home and a pharmacy run to fit in: the pharmacy comes to you, while you stay at their side.
Some treatments expose you to other people's eyes. The sealed parcel protects your privacy right up to delivery.
Frequent questions
What we are asked first.
Who prepares and who delivers my order?
Can I order with a prescription?
Is the price the same as at the counter?
What if I am not there?
When is my order delivered?
Where can you deliver?
How is my health data protected?
Your pharmacy is waiting.
Download the app, choose your pharmacy, and keep the counter in your pocket. In French, German and English.
For pharmacies
Your digital counter. Your rules.
A home-delivery channel that stays yours: your catalogue, your prices, your staff, your professional authority. Medelu provides the technology; the pharmacy keeps the hand.
Why join
What the pharmacy gains, and what it never gives up.
Home delivery adds to your business: patients who cannot come in remain your patients, instead of becoming someone else's channel.
A status-driven queue, named roles, a time-stamped history, accounting export: the back office structures what used to happen on paper and by phone.
No replacement of your software: the platform is designed to work with your existing environment, and the dashboard is learned in one on-site session.
The patient chooses their pharmacy and stays attached to it. Medelu never steps between you: not in the advice, not in the relationship, not in the commercial data.
IN GERMANY, EXPRESS MEDICINE-DELIVERY PLATFORMS DISAPPEARED BETWEEN 2022 AND 2024 · PHARMACY-ANCHORED DELIVERY, AS MEDELU PLANS IT, TOOK HOLD · GERMAN TRADE PRESS, 2022-2024
The dashboard Available
Every order, its status, its proof, its export.
Our commitments
Six non-negotiable commitments, written into the architecture.
Every order is validated by a pharmacist, who can refuse or cancel it at any moment.
The price of the medicine goes to the pharmacy in full. Medelu earns a commission on the delivery fee only.
The patient chooses their pharmacy; no paid placement, no default, no incentive steers them.
Every parcel is prepared and sealed at the pharmacy, then delivered by a courier it mandates, under contract and under its control: the pharmacy remains responsible right to the door.
Health data hosted in the European Union (Frankfurt, Germany), under the pharmacist's responsibility, never monetised.
Only the name, address and order number appear on the parcel, never its contents.
Medelu provides the technology and the integration. The pharmacy remains responsible for the patient relationship, professional validation, advice and dispensing.
Your software
Built for yourexisting environment.
The platform is designed to work alongside the pharmacy software used in Luxembourg: the declared inventory and prices remain the pharmacy's data. The pharmacy keeps its everyday tools, and the digital channel becomes a natural extension of its counter, not a system that replaces them.
INTEGRATIONS DESIGNED WITH THE VENDORS · PROGRESSIVE ROLL-OUT
Generated from the model: fields, their types and their documentation appear directly in the code editor. Integration becomes an adapter, not a rewrite.
The vendor tries before committing, on a realistic test dataset, risk-free and at its own pace.
The vendor verifies its own reading and obtains an attestation. Certification becomes an advantage, not a constraint.
The referential ships like a versioned product, with a stable channel and a trial channel, not as a file dropped somewhere.
BELGIAN PRECEDENT · THE NATIONAL SOURCE BECAME A CONDITION FOR PRESCRIBING-SOFTWARE CERTIFICATION ON 1 JANUARY 2020
Joining
Four steps, at your pace.
In your pharmacy, on your real cases: one hour is enough to see what changes, and what does not.
Catalogue, prices, delivery hours, team roles: everything is configured with you, on your terms.
The team is trained on site, on the real dashboard, until fully autonomous.
You open home delivery when you are ready, and you can suspend it at any moment.
The business model
Transparent, and in that direction.
The medicine goes in full to the pharmacy. Medelu earns only on the delivery fee.
- No commission on the price of medicines, nor on advice.
- A commission on the delivery fee, on a schedule shared before you join.
- A trial period with no commitment: the pharmacy can suspend or leave the platform.
- An accounting export that details every flow, usable outside the platform.
Pharmacy questions
What owners ask first.
Who decides to accept or refuse an order?
Do we have to change software?
Who carries out home delivery?
What does Medelu see of my commercial data?
Health sovereignty · for institutions
A sovereign standard, right to the patient's door.
Luxembourg's pharmacy network is of great quality; no home-delivery framework exists. Medelu proposes a demanding, traceable and reversible standard, written and governed in Luxembourg, and submits it to institutional dialogue.
The Luxembourg ecosystem
A precious pharmacy network, and under strain.
Seven findings, all sourced: three shown, four folded. The network has not kept pace with the population, demography will weigh, spending is accelerating, and Europe has already switched to e-prescriptions while the dispensing channel has not moved. The European rails have a date; the access question is already on the table.
A · Access
Community pharmacies per 100,000 inhabitants
SOURCE · CONSEIL DE LA CONCURRENCE, SECTOR INQUIRY “MEDICINES AND PHARMACIES”, JUNE 2022, CHART 12 AND PP. 51-52 · PGEU 2019 OR NATIONAL SOURCES · OECD AVERAGE: HEALTH AT A GLANCE 2020
15.6
A little over half the OECD average, barely more than a third of the Belgian network. Measured against the population actually served, cross-border workers included, density falls to 11.74.
Cumulative growth 1996 to 2021, in percent
SOURCE · CONSEIL DE LA CONCURRENCE, JUNE 2022, PP. 51, 52 AND 57 · PERIOD 1996-2021
2× faster
The population grew by 54%, the pharmacy network by 29%. The pharmacy concession structurally limits its extension: each demographic wave translates into a heavier load on existing pharmacies, and a longer trip for the patient.
Resident population by age group, on 1 January
SOURCE · EUROSTAT, EUROPOP2025 POPULATION PROJECTIONS, BASELINE (PROJ_25NP) · POLYPHARMACY: J CLIN MED, 2025, SHARE DATA
× 2.2
The 75-plus double between 2026 and 2050; the 65-plus grow by 87%. 29.2% of the 65-plus already take at least five medicines a day. The access infrastructure has to exist before the wave, not during it.
Spending, in two findings2 charts
B · Spending
Health-insurance spend, medicines in community pharmacies, in millions of euros
SOURCE · CNS, HEALTH-MATERNITY INSURANCE BUDGET TABLES, YEARS 2019 TO 2024, LINE “MEDICINES, COMMUNITY PHARMACIES” · IGSS, REPORT TO THE QUADRIPARTITE, OCTOBER 2025
+50%
In six years, and +10.8% in 2024 alone. The CNS still expects +8.5% in 2025 and +8.2% in 2026. Volume grows; the mode of dispensing has been unchanged for decades.
Current health expenditure, euros per inhabitant, 2023
SOURCE · EUROSTAT, HLTH_SHA11_HF, CURRENT HEALTH EXPENDITURE PER INHABITANT, 2023 (PROVISIONAL) · GDP PER CAPITA IN PPS: EUROSTAT, PRELIMINARY ESTIMATES 2024
1st in the Union
No country in the Union devotes more resources to health per inhabitant. The resources exist; the access channel for prescribed medicine stops at the pharmacy's door.
Digital, in two findings2 charts
C · Digital
Digital Decade 2025 indicators, Luxembourg, out of 100
businesses
citizens
5G
(very high capacity)
records
SOURCE · EUROPEAN COMMISSION, DIGITAL DECADE COUNTRY REPORT 2025, LUXEMBOURG
76.1
Europe's digital champion, except in health: citizens' access to their electronic health records is the only public indicator lagging, below the Union average.
E-prescriptions in Germany, share of prescriptions
SOURCE · GEMATIK AND ABDA, 2025 · EUROPEAN DEADLINE FOR E-PRESCRIPTION EXCHANGE: MARCH 2029
0.5 → 90%
In two years. Luxembourg has none of the three digital pillars: no generalised e-prescription, no online sale of prescription medicines, no reimbursed-delivery framework.
Data and integration Configurable
Beneath the operations, a data layer that connects what is fragmented.
Pharmacy operations produce precious information, scattered across software, lists and documents. Medelu designs a configurable integration layer, built around each pharmacy's systems, topped by an assistance layer whose every action remains subject to the professional.
EXPLODED VIEW · THE COLUMNS FOLLOW ONE RECORD ACROSS THE FOUR LAYERS · DEMONSTRATION DIAGRAM · CONFIGURABLE CAPABILITIES
0668201 · DAFALGAN FORTE 1GSTOCK ×8 · MÀJ 08:120668201 · PRIX TTC 3,67 €TVA 3 % · REMBOURSABLE ·NOTICE FR · DE · ENPHOTOS DU CONDITIONNEMENT#33E · 1 LIGNE · REÇUEHORODATÉE 08:13LUN 08:00 – 18:00STATUT LIVRAISON · ACTIF08:14:02 · ACTION TRACED · LINKED TO 3 OBJECTS · AUTOMATIC LOGDEMONSTRATION DATA · CONFIGURABLE CAPABILITIES, BUILT AROUND EACH PHARMACY'S SYSTEMS · NO NATIONAL INFRASTRUCTURE DEPLOYED · NO PATIENT DATA
Connect without re-typing. The pharmacy's existing data is ingested from its systems of origin, with its provenance preserved.
Make reliable through verifiable rules. Graduated, machine-readable quality checks, applied before any use.
Structure by meaning. Real objects of the trade, links that are facts, actions that carry their conditions: the model describes pharmacy as it is practised.
Propose, never decide. The intelligence layer formulates cited, verifiable proposals; execution belongs to the professional.
By role and by purpose. Every access is assigned, justified and logged. No commercial data of an identified pharmacy circulates.
Ready for Europe. An architecture designed for the profession's referentials and Europe's e-health deadlines, governed locally.
Illustration of a configurable capability. No national medication data, no patient data.
Intelligence Human-controlled
From structured data to assisted workflows.
On a structured base, complex information becomes queryable and analysis becomes operational visibility. One principle never changes: no assisted action executes without a professional's confirmation.
Every step is logged
Two verifiable properties, not promises: an action whose criteria are not met cannot be submitted, the control is structural rather than declarative; and the log is automatic, not optional: you cannot act without leaving a trace tied to the objects you changed.
The assistants wired to the model each work within a declared scope, cite the objects they rely on, and carry explicit forbidden acts: none can publish, correct, order, substitute or transmit. The tool that triggers an action is configured for human confirmation, without exception.
What Medelu does not do: no autonomous clinical recommendation, no automated pharmaceutical decision, no access to national medication data. Intelligence serves the professional; it does not replace them.
What becomes possible Configurable
Three lists describe the product. None says whether it can be found.
The national referentials answer the question “what is this product”. None answers “can I get it today”. That second half is born of pharmacies' daily work, and today exists nowhere. Building it remains, at every step, the sector's choice.
records: prices, reimbursement, composition, parapharmacy.
authorised numbers, with the authorisation number and the holder.
marketed, of which 4,231 reimbursed, with rates and conditions.
What is reserved. What arrives tomorrow. What a patient left without getting.
This second half cannot be bought: it can only grow out of the pharmacies' daily work, declaration by declaration, where the platform already operates.
COUNTS · MEDELU AUDIT, APRIL 2025, AND OFFICIAL LISTS AS OF 1 JULY 2026 · SHORTAGES: CONSEIL DE LA CONCURRENCE, SECTOR INQUIRY, 2022 (AROUND EIGHT MEDICINES OUT OF STOCK ON ANY GIVEN DAY)
Thirty-six automations. Eight acts we never automate.
The complete chain is inventoried, from the referential to billing. Each automation is classed by nature, because its nature determines what is allowed.
The inventory, in detail24 + 7 + 5 + 8
A written formula, or an official fact propagating through links. Replayable, verifiable.
Forecasting, detection, classification. Measured in variance, never presented as exact.
Proposals on unstructured input, always verified by a deterministic check behind.
Neither the law nor professional responsibility allows them to be moved.
The eight acts we never automate
- The reasoned opinion of the Medical Board
- The decision to add to the positive list
- Creating or extending a generic group
- Informing the patient about a substitution
- The pharmacist's dispensing decision
- The owner's approval of a preparation
- Arbitrating a disagreement between official sources
- Putting an assistant into service, by the monitoring committee
Six capabilities, each with its guardrail.
Six availability statuses aligned with neighbouring countries. A derived signal requires at least two concordant independent sources.
GUARDRAIL · PUBLICATION IS A GOVERNED ACTION, SUBMITTED BY THE AUTHORITY, NEVER AN AUTOMATIONOnly the pharmacies holding the batch are notified, with quantity and location. Acknowledgement, follow-up, defensible history.
GUARDRAIL · THE AUTHORITY SEES AGGREGATED PROGRESS, WITH NO COMMERCIAL AND NO PATIENT DATAWhat could not be dispensed leaves no trace today. One click at the counter makes it measurable, and strain becomes visible before the shortage.
GUARDRAIL · AGGREGATED, THRESHOLDED, GEOGRAPHIC SIGNAL · NO PHARMACY RE-IDENTIFIABLEThe useful answer is “three pharmacies within fifteen kilometres”, never “pharmacy X holds forty-two”. Participation is voluntary, reference by reference.
GUARDRAIL · QUANTITIES, PURCHASE PRICES AND VOLUMES OF AN IDENTIFIED PHARMACY NEVER CIRCULATEA supplier failure, a seasonal surge: a scenario is evaluated on an isolated branch containing only the differences.
GUARDRAIL · NO RESULT MODIFIES PRODUCTION · THE DECISION REMAINS A GOVERNED ACTIONLuxembourg law already pays for data quality: since 1993, the rebate owed by the pharmacist drops from 5 % to 0.25 % when four categories of data are transmitted electronically. A referential valid on the dispensing date makes that check automatic.
GUARDRAIL · THE MEDICAL BOARD'S REASONED OPINION REMAINS A HUMAN JUDGEMENT, RESERVED BY LAWWhat we deliver, what we propose, what we rule out.
A proposal claiming to do everything would not be credible. Here is the complete map, including the right-hand column, which makes the other two worthy of trust.
- A canonical referential, with graduated quality rules
- Versioned publication, history and export, published reconciliation
- Documents, images and four languages, Luxembourgish included
- Time series and geography, stable identifiers
- Hosting, permissions, encryption, compartmentalisation
- Declared availability and unmet demand
- Batch-level recall coordination
- Strain detection and measurement of real processes
- Digital twin and scenarios
- Governed assistants, on human confirmation
- Framed secondary use, for research and public health
- Patient-specific clinical decision support, which would cross the medical-device boundary
- Patient data at individual grain, with no legal basis here
- Unapproved automation on a regulatory fact
- Unsupervised discovery on commercial data
The right-hand column is not a list of things we cannot do. It is a list of things the architecture allows, and that we refuse to propose because they would cross a regulatory boundary, a legal basis or a governance limit.
CONTEXT · EUROPEAN HEALTH DATA SPACE REGULATION: SECONDARY ACCESS BINDING FROM 2029, A STRUCTURED REFERENTIAL IS THE ENTRY CONDITION · OECD, 2026: HEALTH-DATA INTEROPERABILITY REPRESENTS BETWEEN 2.7 AND 6.6 % OF ANNUAL HEALTH SPENDING, AN ORDER OF MAGNITUDE, NOT A PROMISE · GRAND-DUCAL REGULATION OF 23 DECEMBER 1993 (REBATE CONDITIONAL ON ELECTRONIC TRANSMISSION)
Our proposal
The delivery standard, in five blocks of requirements.
A home-delivery framework worthy of the name must satisfy five blocks of requirements at once. That is the standard Medelu proposes, and to which the platform submits itself.
Validation by a pharmacist, refusal possible at any moment, no automated decision.
Sealed parcel, invisible contents, tracked delivery under the pharmacy's responsibility.
Every step time-stamped, from receipt to proof of delivery, exportable log.
Health data hosted in the European Union (Frankfurt, Germany), never monetised, logged access.
Free choice of pharmacy, no paid placement, no commission on medicines.
The principle that carries the whole: delivery is the extension of the act of dispensing. A demanding standard disadvantages, by construction, any operator unable to keep the medicine under professional supervision, whoever they are.
The cost
Who pays what, transparent end to end.
Three flows, no mystery: medicine reimbursement follows the usual procedure, delivery fees are displayed and separate, and no flow is diverted.
CNS coverage of medicines follows exactly the pharmacy's usual procedure, as at the counter. Delivery does not change it, does not replace it and does not interfere with it: the medicine's reimbursement circuit remains the pharmacy's.
Delivery fees are invoiced by the pharmacy, shown before payment, separate from the price of the medicine, with their own VAT line (17% versus 3% on the medicine). They are not covered by health insurance, and nothing is hidden in the product price.
The patient pays their whole order to the pharmacy, the sole merchant. The payment provider allocates all funds to the pharmacy, settles Medelu's invoices on its behalf and pays it the balance: Medelu takes no commission on medicines and never receives the patient's money.
MEDICINE REIMBURSEMENT FOLLOWS THE CNS RULES IN FORCE, IDENTICAL AT THE PHARMACY AND AT HOME · DELIVERY FEES ARE SHOWN BEFORE PAYMENT, WITH THEIR OWN VAT LINE
The proposed approach
A pilot, not a roll-out.
Medelu proposes to start small, measure publicly, and leave the authorities in charge of what follows. The system is built, field-tested under pharmaceutical supervision and ready to be measured. Nothing here is presented as settled: it is a proposal, open for discussion.
A restricted number of volunteer pharmacies, a geographic scope and a catalogue defined with the authorities.
Delivery safety, lead times, incidents, pharmacy and patient satisfaction: measured and shared.
Authorities, the profession and the platform around the same table, at regular intervals.
Explicit stop criteria, defined before launch. If the pilot does not prove itself, it stops.
The existing on-call service stays as it is; the pilot changes nothing about it.
No charge on the medicine; delivery fees are shown to the patient before payment, and their schedule communicated to pharmacies before joining.
The dialogue
To whom we submit this standard.
THESE EXCHANGES ARE UNDER WAY OR TO COME · NO AGREEMENT IS PRESENTED HERE AS SETTLED
Let's build the framework, together.
A detailed presentation, a technical file or a substantive discussion: we answer institutions with the same level of rigour we propose.
Let's talk about your pharmacy.
One demonstration is enough to see what Medelu changes day to day, and what stays exactly as it is today: your professional authority.
The documentation
The detail, in black and white, for those who want to read it all.
Checks, traceability, legal framework, delivery standard, data model: every subject, in full text and sourced. Click to open the sheet.
Twelve papers: access, the patient journey, the verified account, the pharmacist's tools, traceability, hand-over, the prescription, health data, the legal framework, the delivery standard, the European comparison and the data model.
Open the documentation